Alexander M. Cryer
Impact in
- Pharmaceutical Science top 5%
- Advancements in Transdermal Drug Delivery
-
- interferon and immune responses
- Immunotherapy and Immune Responses
Papers in
-
- Immunotherapy and Immune Responses 4
- interferon and immune responses 4
-
- RNA Interference and Gene Delivery 3
- Co-authors
- Andrew J. Thorley (3 shared papers)Natalie Artzi (9 shared papers)Pere Dosta (8 shared papers)Shiran Ferber (3 shared papers)Michaela Prado (4 shared papers)Ulrich H. von Andrian (1 shared paper)Walid S. Kamoun (1 shared paper)Steven Langston (1 shared paper)
- Journals
- ACS Nano (1 paper)Advanced Functional Materials (1 paper)Advanced Materials (1 paper)ACS Applied Materials & Interfaces (1 paper)Proceedings of the National Academy of Sciences (1 paper)
- Partner nations
- United StatesUnited KingdomIsrael
In The Last Decade
Alexander M. Cryer
12 papers receiving 426 citations
Alexander M. Cryer's Hit Papers
Peers
Comparison fields: 5 of 78
- Pharmaceutical Science 59
- Immunology 157
- Biomaterials 95
- Biomedical Engineering 141
- Dermatology 18
Countries citing papers authored by Alexander M. Cryer
This map shows the geographic impact of Alexander M. Cryer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander M. Cryer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander M. Cryer more than expected).
Fields of papers citing papers by Alexander M. Cryer
This network shows the impact of papers produced by Alexander M. Cryer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander M. Cryer. The network helps show where Alexander M. Cryer may publish in the future.
Co-authors
The 25 scholars most cited alongside Alexander M. Cryer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 127 | |
| 2 | Investigation of the enhanced antitumour potency of STING agonist after conjugation to polymer nanoparticles Hit paper breakdown → | 2023 | 115 |
| 3 | 2022 | 51 | |
| 4 | 2019 | 39 | |
| 5 | 2019 | 37 | |
| 6 | 2024 | 29 | |
| 7 | 2021 | 16 | |
| 8 | 2023 | 9 | |
| 9 | 2025 | 7 | |
| 10 | 2022 | 1 | |
| 11 | 2025 | 1 | |
| 12 | 2016 | 1 |
About Alexander M. Cryer
Alexander M. Cryer is a scholar working on Immunology, Molecular Biology, Oncology, Biomedical Engineering and Pulmonary and Respiratory Medicine, having authored 12 papers that have together received 433 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (4 papers), interferon and immune responses (4 papers), RNA Interference and Gene Delivery (3 papers), Lung Cancer Research Studies (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Lung Cancer Diagnosis and Treatment (2 papers), Click Chemistry and Applications (1 paper) and Toxoplasma gondii Research Studies (1 paper). The work is most often cited by research in Pharmaceutical Science (59 citations), Immunology (157 citations), Biomaterials (95 citations), Biomedical Engineering (141 citations) and Dermatology (18 citations). Alexander M. Cryer has collaborated with scholars based in United States, United Kingdom and Israel. Frequent co-authors include Andrew J. Thorley, Natalie Artzi, Pere Dosta, Shiran Ferber, Michaela Prado, Ulrich H. von Andrian, Walid S. Kamoun, Steven Langston, Jianing Wang and Miles A. Miller. Their work appears in journals such as ACS Nano, Advanced Functional Materials, Advanced Materials, ACS Applied Materials & Interfaces and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.